Natrol wraps up sale to Aurobindo
Nutritional supplement maker Natrol Inc. has closed its agreement to be acquired by Aurobindo Pharma USA Inc. (APUSA) for $132.5 million. Natrol said late Monday that APUSA, a subsidiary of India-based generic drug and active pharmaceutical ingredient maker Aurobindo Pharma Ltd.